Related Experiment Video
Updated: May 30, 2026

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
Personalized genomic medicine: lessons from the exome
Benjamin D Solomon1, Daniel E Pineda-Alvarez, Donald W Hadley
1Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA. solomonb@mail.nih.gov
Whole-exome sequencing revealed a novel genetic risk factor, a CPS1 mutation, for neonatal pulmonary hypertension in a VACTERL association patient. This finding enables targeted preventative care for individuals with this mutation.
Area of Science:
- Genomics
- Medical Genetics
- Pediatric Cardiology
Background:
- Genomic sequencing is crucial for identifying genetic factors in human diseases.
- Incidental findings from sequencing can offer significant scientific and clinical value.
- VACTERL association is a complex congenital condition with various potential complications.
Observation:
- Whole-exome sequencing was performed on a neonate with VACTERL association and severe post-surgical pulmonary hypertension.
- A heterozygous mutation in the CPS1 gene was identified as a potential novel genetic risk factor.
- Newborn screening of the patient's identical twin provided supporting evidence for the mutation's role.
Findings:
- The CPS1 mutation, combined with surgical stress, may lead to pulmonary artery hypertension.
- This hypertension is potentially linked to insufficient nitric oxide production.
- The study highlights the significance of incidental genetic discoveries.
Implications:
- Identification of the CPS1 mutation allows for targeted preventative strategies for the patient and relatives.
- This research underscores the clinical utility of whole-exome sequencing in uncovering unexpected genetic risks.
- Understanding these genetic underpinnings can improve patient care and inform future genetic counseling.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Genomics
Pharmacogenomics: Identification of New Drug Targets
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu